Signs of weakness in Apple and Amazon income

For the quarter which ended in March, Apple and Amazon reported high and low online numbers that beat the expectations of analysts, joining their “magnificent seven” comrades with alphabet homologists, Microsoft and Meta platforms on the podium. (Full driving of Tesla is still helping the company of electric vehicles cross the line.)

That said, the financial results of Apple and Amazon had weaknesses under the hood. The Division of Apple Services, which includes offers such as advertising, iCloud and Apple TV +, has failed to estimate. This counts because it is the second highest income generator for Apple, dragging only its iPhone division. As for Amazon, its Cloud Division – the largest cloud supplier in the world – has not met income expectations for the third consecutive time, which suggests that growth slows down.

The CEOs of the two companies also reported the challenge of predicting how the prices will affect not only the current quarter, but also the coming year. Despite the excitement manifested by investors on Microsoft and Meta – as shown in the gatherings in the actions of these companies Thursday – the nests in Poule still exist for the road to Big Tech.

Note: CNBC Daily Open will be absent on May 5, Monday, for holidays in Singapore. The newsletter will return on May 6 on Tuesday.

China assessing the American offer to negotiate
High US officials have recently contacted “through relevant games on several occasions”, in the hope of starting negotiations with China on prices, a spokesman for the Beijing Ministry of the Trade in a statement on Friday. Chinese authorities have declared that they assess the openings, but have reiterated their request for the United States to remove all unilateral prices. Analysts also warned that the achievement of a complete agreement will be complex and takes time.

The benefits of Apple services have missed expectations
Apple Generat of the second Commercial quarter Thursday who beat the expectations of Wall Street. However, the company’s supervised services division failed to estimate, and CEO Tim Cook said it was “very difficult” to predict the impact of prices beyond June. Furthermore, Apple said it would appeal after a court concluded that the company had voluntarily violated an injunction of 2021 which came out of the Epic Games.

The growth of the cloud in Amazon slows down
Amazon reported better than expected results for the first quarter. But revenues at Amazon Web Services have increased at a slower than expected pace, a third lack of consecutive income. The company has published light advice, noting that “prices and commercial policies” and “recession fears” could change its forecasts. However, CEO Andy Jassy said it was “optimistic” that the company could emerge from stronger uncertainty.

Chartered Standard exceeds estimates
Standard chartered According to the benefits of the first quarter on Friday, which beat the expectations of profits, thanks to strong growth in its wealth management, the world markets. and global banking companies. Bank’s benefit before the tax for the three months closed March was 2.1 billion dollars, compared to $ 1.91 billion during the same period a year ago. Investors applauded the results, sending Standard chartered Share 2.75% more.

Large technological actions increase the American clues
American actions advanced Thursday, stimulated by jumps Meta-platforms And Microsoft Actions after the companies have declared pink profits. THE S&P 500 won 0.63%, the Industrial average Dow Jones Addition of 0.21% and technology Nasdaq Composite climbed by 1.52%. The Asia-Pacific markets increased on Friday. The Hong Kong Hang Seng index added about 1.7% on the news that China estimates the prospect of talks with the United States

(Pro) Big Tech is back?
A pair of solid profits from Microsoft and Meta seems to have rekindled the excitement around the trade in artificial intelligence and can, at least temporarily, push the tariff concerns of the spirit of investors. However, some market observers believe that the rally in small Microsoft groups is unique.

In the agreement: Roche and Zealand Pharma at $ 5.3 billion in obesity medication

The Ballon Obesity Medicines Market can have a new competitor after Roche has entered into an agreement of $ 5.3 billion to develop the Danish biotechnology weight loss candidate Biotech Zealand Pharma.

The agreement, announced in March and is expected to conclude in the second quarter, marks the last offer of the Swiss pharmaceutical company to compete with heavy goods vehicles Novo Nordisk and Eli Lilly. Roche has built a portfolio of obesity treatment drugs in recent years.

Zealand Pharma’s Amyline Petrelintide analog could distinguish the potential medication. Amyline’s analogues, an emerging form of weight loss treatment, imitate a hormone co-skid with insulin in the pancreas to increase satiety. This differs from currently widespread GLP-1 obesity drugs such as Zepbound and Wegovy, which imitate the incretinous hormones produced in the intestine to remove appetite.